Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.
Gangliogliomas constitute the most frequent tumour entity in patients with temporal lobe epilepsy. The characteristic histopathological admixture of glial and neuronal elements, the focal nature and their differentiated phenotype and benign biological behaviour suggest an origin from a developmentally compromised or dysplastic precursor lesion. The present study analysed TSC1 and TSC2 genes as potential candidates involved in the pathogenesis of this intriguing neoplasm. Recent data suggest that both genes play a role in cortical differentiation and growth control. DNA sequence analysis of TSC1 and TSC2 was studied in 20 patients with gangliogliomas. Fifteen of these tumours (75%) carried polymorphisms in the TSC2 gene. The frequency of these polymorphisms was significantly increased in intron 4 (12.5%) and exon 41 (15%) compared to control individuals (8.1 and 6.5%, respectively, n = 100). A somatic mutation in intron 32 of the TSC2 gene was encountered in one patient. In the TSC1 gene, seven polymorphisms occurred as a combination of base exchanges in exon 14 and intron 13. No mutations were observed in this gene. Laser microdissection and harvesting of individual neuronal and glial elements identified the intron 32 mutation within the glial portion but not in dysplastic neurones of the tumour. The data demonstrate numerous polymorphisms as well as a novel TSC2 mutation in gangliogliomas from patients with chronic epilepsies. The selective detection of the TSC2 mutation within the glial component of a ganglioglioma suggests that the glioma portion has undergone clonal evolution in this case.
Becker
A J
AJ
Department of Neuropathology, University of Bonn Medical Center, Bonn, Germany.
Löbach
M
M
Klein
H
H
Normann
S
S
Nöthen
M M
MM
von Deimling
A
A
Mizuguchi
M
M
Elger
C E
CE
Schramm
J
J
Wiestler
O D
OD
Blümcke
I
I
D001932:Brain Neoplasms / Q000235:genetics*; D002908:Chronic Disease; D004252:DNA Mutational Analysis; D017931:DNA Primers; D004833:Epilepsy, Temporal Lobe / Q000235:genetics; D018303:Ganglioglioma / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D017354:Point Mutation; D011506:Proteins / Q000235:genetics*; D012097:Repressor Proteins / Q000235:genetics*; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins
D017931:DNA Primers; D011506:Proteins; D012097:Repressor Proteins; C000624650:TSC1 protein, human; C000624653:TSC2 protein, human; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins